$7.19
0.56% today
Nasdaq, Jul 14, 04:18 pm CET
ISIN
US31572Q8087
Symbol
FGEN
Sector
Industry

FibroGen, Inc. Stock price

$7.15
-0.58 7.44% 1M
-7.57 51.43% 6M
-6.09 45.99% YTD
-17.33 70.80% 1Y
-282.60 97.53% 3Y
-1,021.85 99.31% 5Y
-560.85 98.74% 10Y
-542.85 98.70% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
-0.20 2.72%
ISIN
US31572Q8087
Symbol
FGEN
Sector
Industry

Key metrics

Basic
Market capitalization
$28.9m
Enterprise Value
$86.5m
Net debt
$57.6m
Cash
$33.6m
Shares outstanding
4.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.3 | 2.8
EV/Sales
0.8 | 8.5
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-105.2%
Return on Equity
21.1%
ROCE
-124.9%
ROIC
-122.3%
Debt/Equity
-0.4
Financials (TTM | estimate)
Revenue
$102.9m | $10.2m
EBITDA
$-112.5m | $-69.5m
EBIT
$-114.7m | $-72.3m
Net Income
$-10.0m | $-50.0m
Free Cash Flow
$-76.3m
Growth (TTM | estimate)
Revenue
-38.6% | -65.6%
EBITDA
50.9% | 45.9%
EBIT
51.6% | 44.8%
Net Income
95.8% | -5.0%
Free Cash Flow
72.2%
Margin (TTM | estimate)
Gross
109.7%
EBITDA
-109.4% | -682.0%
EBIT
-111.5%
Net
-9.7% | -490.6%
Free Cash Flow
-74.1%
More
EPS
$-2.5
FCF per Share
$-18.9
Short interest
4.8%
Employees
225
Rev per Employee
$130.0k
Show more

Is FibroGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

FibroGen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a FibroGen, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a FibroGen, Inc. forecast:

Buy
75%
Hold
25%

Financial data from FibroGen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
103 103
39% 39%
100%
- Direct Costs -9.94 -9.94
124% 124%
-10%
113 113
11% 11%
110%
- Selling and Administrative Expenses 35 35
67% 67%
34%
- Research and Development Expense 66 66
73% 73%
65%
-112 -112
51% 51%
-109%
- Depreciation and Amortization 2.20 2.20
72% 72%
2%
EBIT (Operating Income) EBIT -115 -115
52% 52%
-112%
Net Profit -10 -10
96% 96%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about FibroGen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FibroGen, Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGen's common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the Compan...
Neutral
GlobeNewsWire
about one month ago
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025.
Neutral
Seeking Alpha
2 months ago
FibroGen, Inc. (NASDAQ:FGEN ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Joanne Greller - LifeSci Advisors Thane Wettig - Chief Executive Officer David DeLucia - Chief Financial Officer Conference Call Participants Andy Hsieh - William Blair Matthew Keller - H.C. Wainwright Operator Good day and thank you for standing by.
More FibroGen, Inc. News

Company Profile

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Head office United States
CEO Thane Wettig
Employees 225
Founded 1993
Website www.fibrogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today